This brand name is authorized in Canada, Estonia, Finland, France, Hong Kong, Ireland, Japan, Lithuania, Malta, Netherlands, Poland, Tunisia, Turkey, United Kingdom, South Africa
The drug FUNGIZONE contains one active pharmaceutical ingredient (API):
|
1
Amphotericin B
UNII 7XU7A7DROE - AMPHOTERICIN B
|
|
Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A01AB04 | Amphotericin B | A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment |
| A07AA07 | Amphotericin B | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics |
| G01AA03 | Amphotericin B | G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics |
| J02AA01 | Amphotericin B | J Antiinfectives for systemic use → J02 Antimycotics for systemic use → J02A Antimycotics for systemic use → J02AA Antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 00029149 |
| Country: EE | Ravimiamet | Identifier(s): 1095689, 1552700, 1619940 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 436444 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 63709997, 64346723, 68211089 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 47028 |
| Country: HK | Department of Health Drug Office | Identifier(s): 00037 |
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 6173001Q1047, 6173400D1035 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1090649 |
| Country: MT | Medicines Authority | Identifier(s): AA1456/00501, AA565/26102 |
| Country: NL | Z-Index G-Standaard | Identifier(s): 12121614 |
| Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 1058, 5436 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100281935, 100418877 |
| Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 6400021, 6400023H |
| Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8682340179022 |
| Country: ZA | Health Products Regulatory Authority | Identifier(s): A/20.1.7/0150 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
